维普中文期刊产品整合服务
5篇 您的检索式:作者名="Mikkael"
    题名 作者 年代 出处 被引量
1Aphase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605 显示文摘Mikkael A Holly G Jeffrey L 2011Blood2011,118,3:1
2A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF)显示文摘Nelli Bejanyan Ramon V. Tiu Azra Raza Ania Jankowska Matt Kalaycio Anjali Advani Josephine Chan Yogen Saunthararajah Lindsey Mooney Jaroslaw P. Maciejewski Mikkael A. Sekeres 2011Cancer2011,,:1
3A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF)显示文摘Nelli Bejanyan Ramon V. Tiu Azra Raza Ania Jankowska Matt Kalaycio Anjali Advani Josephine Chan Yogen Saunthararajah Lindsey Mooney Jaroslaw P. Maciejewski Mikkael A. Sekeres 2011Cancer2011,,16:1
4FISH and SNP-A karyotyping in myelodysplastic syndromes: Improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q)显示文摘Hideki Makishima Manjot Rataul Lukasz P. Gondek Jungwon Huh James R. Cook Karl S. Theil Mikkael A. Sekeres Elizabeth Kuczkowski Christine O’Keefe Jaroslaw P. Maciejewski 2009Leukemia Research2009,,4:1
5Successful use of very low dose subcutaneous decitabine to treat high-risk myelofibrosis with Sweet syndrome that was refractory to 5-azacitidine显示文摘Yang Liu Ali Tabarroki Steven Billings Valeria Visconte Heesun J. Rogers Edy Hasrouni Ricki Englehaupt Matt Kalaycio Mikkael A. Sekeres Yogen Saunthararajah Ramon V. Tiu 2014Leukemia & Lymphoma2014,,2:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费